These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9620038)

  • 1. Problems associated with passively transfused blood group alloantibodies.
    Garratty G
    Am J Clin Pathol; 1998 Jun; 109(6):769-77. PubMed ID: 9620038
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
    Morgan S; Sorensen P; Vercellotti G; Zantek ND
    Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
    Thorpe SJ
    Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants.
    Boctor FN; Bhaskaran M; Sheahan B; Heaton WA; Molmenti E
    Transfusion; 2011 Aug; 51(8):1874-5. PubMed ID: 21831188
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical aspects of Rh immunization. Philip Levine Award Address.
    Mollison PL
    Am J Clin Pathol; 1973 Sep; 60(3):287-301. PubMed ID: 4199486
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
    Sniecinski IJ; Petz LD; Oien L; Blume KG
    Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of thrombocytic alloantibodies of the IgG class with a solid phase immunoassay].
    Mayr WR; de Wit M; Gassner H; Hahn M; Goertz-Kaiser B
    Beitr Infusionsther; 1988; 21():292-5. PubMed ID: 2462995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolysis during immunoglobulin therapy].
    Muñoz J; García A; Jordán C; Rubió A; Ferrán C; Martínez Matos JA
    Sangre (Barc); 1996 Feb; 41(1):72-3. PubMed ID: 8779043
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.
    Eichberg JW; Murthy KK; Ward RH; Prince AM
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1515. PubMed ID: 1466993
    [No Abstract]   [Full Text] [Related]  

  • 12. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
    Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
    Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method.
    Tichelli A; Gratwohl A; Wenger R; Osterwalder B; Nissen C; Burri HP; Speck B
    Transplant Proc; 1987 Dec; 19(6):4632-7. PubMed ID: 3321636
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantibodies and platelet destruction.
    Klein CA; Blajchman MA
    Semin Thromb Hemost; 1982 Apr; 8(2):105-15. PubMed ID: 7043738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing immunoglobulin G therapy in chronic autoimmune neuropathies.
    Berger M
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):144-5. PubMed ID: 25546798
    [No Abstract]   [Full Text] [Related]  

  • 19. Will sialylation change intravenous immunoglobulin therapy in the future?
    Käsermann F; Campbell IK
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose and outcomes in primary immunodeficiency disorders.
    Bonagura VR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):7-9. PubMed ID: 25546743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.